Debbie Callaghan

4.0k total citations
16 papers, 1.5k citations indexed

About

Debbie Callaghan is a scholar working on Physiology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Debbie Callaghan has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 8 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Debbie Callaghan's work include Alzheimer's disease research and treatments (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Trace Elements in Health (4 papers). Debbie Callaghan is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Trace Elements in Health (4 papers). Debbie Callaghan collaborates with scholars based in Canada, United States and China. Debbie Callaghan's co-authors include Wandong Zhang, Danica Stanimirovic, Huaqi Xiong, Lih‐Fen Lue, Douglas G. Walker, Aimee Jones, Hong Cui, Wayne S. Schwark, Jelena Mojsilovic‐Petrovic and Ingrid Rasquinha and has published in prestigious journals such as Journal of Neuroscience, Journal of Neurochemistry and Developmental Biology.

In The Last Decade

Debbie Callaghan

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debbie Callaghan Canada 15 542 540 353 312 291 16 1.5k
Katie Hamm United States 7 1.3k 2.5× 555 1.0× 247 0.7× 319 1.0× 565 1.9× 7 1.9k
Alain Boom Belgium 21 398 0.7× 625 1.2× 159 0.5× 222 0.7× 168 0.6× 36 1.5k
Je‐Seong Won United States 22 560 1.0× 821 1.5× 131 0.4× 216 0.7× 230 0.8× 58 1.6k
Magdalena Zielińska Poland 23 371 0.7× 598 1.1× 105 0.3× 514 1.6× 196 0.7× 71 1.7k
Michel Pierre France 26 239 0.4× 942 1.7× 229 0.6× 280 0.9× 100 0.3× 47 1.9k
Tetsuya Nagayama United States 22 235 0.4× 1.2k 2.2× 177 0.5× 753 2.4× 400 1.4× 38 2.6k
María Delgado‐Esteban Spain 19 305 0.6× 775 1.4× 130 0.4× 228 0.7× 212 0.7× 27 1.4k
Virginia Hovanesian United States 13 791 1.5× 370 0.7× 130 0.4× 126 0.4× 476 1.6× 18 1.4k
Noriaki Mitsuda Japan 19 382 0.7× 1.0k 1.9× 140 0.4× 432 1.4× 222 0.8× 50 1.8k
Suizhen Lin United States 16 943 1.7× 738 1.4× 139 0.4× 629 2.0× 833 2.9× 24 2.2k

Countries citing papers authored by Debbie Callaghan

Since Specialization
Citations

This map shows the geographic impact of Debbie Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie Callaghan more than expected).

Fields of papers citing papers by Debbie Callaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie Callaghan. The network helps show where Debbie Callaghan may publish in the future.

Co-authorship network of co-authors of Debbie Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie Callaghan. A scholar is included among the top collaborators of Debbie Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie Callaghan. Debbie Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Li, Yan, Hong Liu, Debbie Callaghan, et al.. (2017). Apolipoprotein E Isoforms Differentially Regulate Alzheimer’s Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro. Journal of Alzheimer s Disease. 57(4). 1265–1279. 23 indexed citations
2.
Callaghan, Debbie, et al.. (2014). Stimulation of Insulin Signaling and Inhibition of JNK-AP1 Activation Protect Cells from Amyloid-β-Induced Signaling Dysregulation and Inflammatory Response. Journal of Alzheimer s Disease. 40(1). 105–122. 23 indexed citations
3.
Zhang, Wandong, Huaqi Xiong, Debbie Callaghan, et al.. (2013). Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging. Fluids and Barriers of the CNS. 10(1). 13–13. 34 indexed citations
4.
Zeng, Yu, Debbie Callaghan, Huaqi Xiong, et al.. (2012). Abcg2 deficiency augments oxidative stress and cognitive deficits in Tg‐SwDI transgenic mice. Journal of Neurochemistry. 122(2). 456–469. 24 indexed citations
5.
Xiong, Huaqi, Debbie Callaghan, Jolanta Wodzinska, et al.. (2011). Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer’s disease. Neuroscience Bulletin. 27(4). 221–232. 87 indexed citations
6.
Shen, Shanshan, Debbie Callaghan, Camille A. Juźwik, et al.. (2010). ABCG2 reduces ROS‐mediated toxicity and inflammation: a potential role in Alzheimer’s disease. Journal of Neurochemistry. 114(6). 1590–1604. 94 indexed citations
7.
Callaghan, Debbie, Douglas G. Walker, Lih‐Fen Lue, et al.. (2009). Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiology of Disease. 34(1). 95–106. 185 indexed citations
8.
Xiong, Huaqi, Debbie Callaghan, Aimee Jones, et al.. (2009). ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40Peptides. Journal of Neuroscience. 29(17). 5463–5475. 166 indexed citations
9.
Callaghan, Debbie, Jianying Bai, Aimee Jones, et al.. (2008). P4‐182: Inhibition of ABCG2 transport function by amyloid‐beta peptide augments cellular oxidative stress and inflammatory gene expression in cells. Alzheimer s & Dementia. 4(4S_Part_22). 3 indexed citations
10.
11.
Xiong, Huaqi, Debbie Callaghan, Aimee Jones, et al.. (2007). Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production. Neurobiology of Disease. 29(3). 422–437. 231 indexed citations
12.
Zhang, Wandong, et al.. (2006). Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1β (IL-1β) in astrocyte cultures. Journal of Neuroimmunology. 174(1-2). 63–73. 103 indexed citations
13.
Hou, Sheng‐Tao, Debbie Callaghan, Irene E. Hill, et al.. (2000). The Transcription Factor E2F1 Modulates Apoptosis of Neurons. Journal of Neurochemistry. 75(1). 91–100. 100 indexed citations
14.
Callaghan, Debbie, et al.. (1999). Neural Precursor Cells Differentiating in the Absence of Rb Exhibit Delayed Terminal Mitosis and Deregulated E2F 1 and 3 Activity. Developmental Biology. 207(2). 257–270. 67 indexed citations
15.
Callaghan, Debbie & Wayne S. Schwark. (1980). Pharmacological modification of amygdaloid-kindled seizures. Neuropharmacology. 19(11). 1131–1136. 75 indexed citations
16.
Callaghan, Debbie. (1979). Involvement of catecholamines in kindled amygdaloid convulsions in the rat. Neuropharmacology. 18(6). 541–545. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katie Hamm Breakdown of academic impact, for papers by Alain Boom Breakdown of academic impact, for papers by Je‐Seong Won Breakdown of academic impact, for papers by Magdalena Zielińska Breakdown of academic impact, for papers by Michel Pierre Breakdown of academic impact, for papers by Tetsuya Nagayama Breakdown of academic impact, for papers by María Delgado‐Esteban Breakdown of academic impact, for papers by Virginia Hovanesian Breakdown of academic impact, for papers by Noriaki Mitsuda Breakdown of academic impact, for papers by Suizhen Lin
Rankless by CCL
2026